The World of Health & Medicine News

New lasso-shaped antibiotic kills drug-resistant bacteria

New lasso-shaped antibiotic kills drug-resistant bacteria

Researchers at McMaster University have identified a new molecule with antibiotic activity against a range of disease-causing bacteria, including those resistant to existing drugs.

The new molecule — isolated from soil samples taken from a laboratory technician’s garden — is called lariocidin due to its lasso-shaped structure.

The team say that in addition to its potent antibiotic activity, the molecule also shows low toxicity towards human cells, making it a promising molecule in the fight against drug-resistant infections.

spot_img

Explore more

spot_img

Chinese brain chip project speeds up human trials after first success

Chinese brain chip project speeds up human trials after first success A tie-up between a Chinese research institute and tech company said on Monday that...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by 94 percent According to results published in the New England Journal of Medicine: In a...

Novo Nordisk to license obesity drug from Lexicon in up to...

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O),...

Vykat XR approved for genetic binge eating disorder

For the first time/ Vykat XR approved for genetic binge eating disorder The U.S. Food and Drug Administration (FDA) on Wednesday approved Soleno Therapeutics’ drug to...

Keytruda subcutaneous injection to launch on October 1

Keytruda subcutaneous injection to launch on October 1 Merck & Co. said Thursday it plans to launch a subcutaneous injection of its best-selling cancer immunotherapy,...

Buying an autoimmune disease drug for $1.3 billion

Sanofi/ Buying an autoimmune disease drug for $1.3 billion Sanofi announced Thursday that it has agreed to buy the biopharmaceutical company’s autoimmune disease drug Dren Bio...

US FDA approves Sanofi’s bleeding disorder therapy

US FDA approves Sanofi's bleeding disorder therapy The U.S. Food and Drug Administration approved French drugmaker Sanofi's (SASY.PA), opens new tab hemophilia therapy, introducing a new...

Monjaro weight loss drug hits Indian market

Monjaro weight loss drug hits Indian market Eli Lilly has launched its best-selling diabetes and weight loss drug Monjaro in India, beating rival Novo Nordisk...